British Patient Capital, funding innovation from Sheffield
Find out more about British Patient Capital-
£2.5bn Core funds and co-investment programme
-
1,190 Innovative high-growth companies in our underlying portfolio (as at 31 March 2023)
-
£1.9bn+ Total commitments to date (as at 31 March 2023)
What we do
Core funds and co-investment programme
Through our core £2.5bn programme we invest in venture and venture growth capital funds, and co-invest alongside those funds in the most promising later-stage UK businesses within our portfolio.
Life Sciences Investment Programme
The Life Sciences Investment Programme (LSIP) is a £200m initiative which makes cornerstone commitments to later stage life sciences venture growth funds with a strong UK focus.
Future Fund: Breakthrough
Future Fund: Breakthrough is a £425m UK-wide programme which encourages private investors to co-invest in growth stage, Research & Development (R&D) UK companies operating in breakthrough technology sectors.
News & insights
Press release
Press release
